FDA Adverse Event Injury Summary report: N

VITALITY 2

MDR report key: 1861050 · Received October 7, 2010

Report

Report Number
2124215-2010-15282
Event Type
Injury
Date Received
October 7, 2010
Date of Event
July 27, 2010
Report Date
November 3, 2011
Manufacturer
GUIDANT CRM CLONMEL IRELAND
Product Code
LWS
Removal / Correction Number
Z-1620-09 TO Z-1621-09
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

SUBSEQUENTLY, BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS DEVICE WAS ELECTIVELY EXPLANTED IN (B)(6) 2011. TO DATE, THE DEVICE HAS NOT BEEN RECEIVED AT BOSTON SCIENTIFIC RETURN PRODUCTS DEPARTMENT. AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED AND/OR THE DEVICE IS RETURNED FOR LABORATORY TESTING.

Additional Manufacturer Narrative · 1

UPON RECEIPT AT OUR POST MARKET QUALITY ASSURANCE LABORATORY, A LONGEVITY CALCULATION CONFIRMED THAT THE DEVICE DID MEET LONGEVITY ESTIMATES PROVIDED IN DEVICE LABELING. HOWEVER, THE DEVICE'S LIFE CELL CAPACITY WAS LESS THAN EXPECTED. PORTIONS OF THE CIRCUITRY, INCLUDING THE BATTERY, WERE ISOLATED AND TESTED. FINAL ANALYSIS CONCLUDED THAT THE PREMATURE BATTERY DEPLETION WAS DUE TO A COMPROMISED LOW-VOLTAGE CAPACITOR, WHICH RESULTED IN A HIGH CURRENT CONDITION. IN SPITE OF THIS COMPROMISED CAPACITOR, TESTING CONFIRMED THAT THE DEVICE HAD NORMAL PACING, SENSING, AND DEFIBRILLATION THERAPY FUNCTIONS.

Additional Manufacturer Narrative · 1

THE AVAILABLE INFORMATION SUGGESTS THAT THIS DEVICE REMAINS IN-SERVICE. THE EVENT WILL BE REOPENED IF ADDITIONAL INFORMATION IS RECEIVED AND/OR THE DEVICE IS RETURNED FOR LABORATORY TESTING.

Description of Event or Problem · 1

--

Description of Event or Problem · 1

--

Description of Event or Problem · 1

BOSTON SCIENTIFIC CRM RECEIVED INFORMATION THAT THIS DEVICE, AT 33 MONTHS, WAS EXHIBITING A MONITORING VOLTAGE OF 2.61 VOLTS. THE CLINIC NURSE ASKED FOR RECOMMENDATIONS FOR DEVICE FOLLOW-UP. TECHNICAL SERVICES ADVISED THAT THIS DEVICE SHOULD BE FOLLOWED ON THE PATIENT'S LATITUDE MONITORING SYSTEM EVERY MONTH UNTIL ELECTIVE REPLACEMENT INDICATOR (ERI) IS TRIGGERED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 VITALITY 2 IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LWS GUIDANT CRM CLONMEL IRELAND T167

Patients

Seq Age Sex Outcome Treatment
1 85 YR Hospitalization| R 0185| T167| 5076